Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.0…

Overview of attention for article published in Lancet Oncology, August 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 73,624 followers.

Good study. But question is whether to make treatment changes given recent @TheLancetOncol publication http://t.co/xydvvINRCF #ASTRO14

Good study. But question is whether to make treatment changes given recent @TheLancetOncol publication http://t.co/xydvvINRCF #ASTRO14

Good study. But question is whether to make treatment changes given recent @TheLancetOncol publication http://t.co/xydvvINRCF #ASTRO14

Short-term androgen suppr and RT vs interm-term androgen suppr and RT, w or w/o zoledronic, in men with LAPC http://t.co/nzbBuGlNY7

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.